276 related articles for article (PubMed ID: 26934645)
1. Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells.
McNaughton M; Pitman M; Pitson SM; Pyne NJ; Pyne S
Oncotarget; 2016 Mar; 7(13):16663-75. PubMed ID: 26934645
[TBL] [Abstract][Full Text] [Related]
2. The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells.
Loveridge C; Tonelli F; Leclercq T; Lim KG; Long JS; Berdyshev E; Tate RJ; Natarajan V; Pitson SM; Pyne NJ; Pyne S
J Biol Chem; 2010 Dec; 285(50):38841-52. PubMed ID: 20926375
[TBL] [Abstract][Full Text] [Related]
3. The sphingosine kinase inhibitor 2-(p-hyroxyanilino)-4-(p-chlorophenyl)thiazole reduces androgen receptor expression via an oxidative stress-dependent mechanism.
Tonelli F; Alossaimi M; Williamson L; Tate RJ; Watson DG; Chan E; Bittman R; Pyne NJ; Pyne S
Br J Pharmacol; 2013 Mar; 168(6):1497-505. PubMed ID: 23113536
[TBL] [Abstract][Full Text] [Related]
4. Native and Polyubiquitinated Forms of Dihydroceramide Desaturase Are Differentially Linked to Human Embryonic Kidney Cell Survival.
Alsanafi M; Kelly SL; Jubair K; McNaughton M; Tate RJ; Merrill AH; Pyne S; Pyne NJ
Mol Cell Biol; 2018 Dec; 38(23):. PubMed ID: 30224516
[TBL] [Abstract][Full Text] [Related]
5. The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In Vivo.
Venant H; Rahmaniyan M; Jones EE; Lu P; Lilly MB; Garrett-Mayer E; Drake RR; Kraveka JM; Smith CD; Voelkel-Johnson C
Mol Cancer Ther; 2015 Dec; 14(12):2744-52. PubMed ID: 26494858
[TBL] [Abstract][Full Text] [Related]
6. From Sphingosine Kinase to Dihydroceramide Desaturase: A Structure-Activity Relationship (SAR) Study of the Enzyme Inhibitory and Anticancer Activity of 4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II).
Aurelio L; Scullino CV; Pitman MR; Sexton A; Oliver V; Davies L; Rebello RJ; Furic L; Creek DJ; Pitson SM; Flynn BL
J Med Chem; 2016 Feb; 59(3):965-84. PubMed ID: 26780304
[TBL] [Abstract][Full Text] [Related]
7. The regulation of p53, p38 MAPK, JNK and XBP-1s by sphingosine kinases in human embryonic kidney cells.
Alsanafi M; Kelly SL; McNaughton M; Merrill AH; Pyne NJ; Pyne S
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Apr; 1865(4):158631. PubMed ID: 31954175
[TBL] [Abstract][Full Text] [Related]
8. Inhibition kinetics and regulation of sphingosine kinase 1 expression in prostate cancer cells: functional differences between sphingosine kinase 1a and 1b.
Lim KG; Tonelli F; Berdyshev E; Gorshkova I; Leclercq T; Pitson SM; Bittman R; Pyne S; Pyne NJ
Int J Biochem Cell Biol; 2012 Sep; 44(9):1457-64. PubMed ID: 22634604
[TBL] [Abstract][Full Text] [Related]
9. The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cells.
Watson DG; Tonelli F; Alossaimi M; Williamson L; Chan E; Gorshkova I; Berdyshev E; Bittman R; Pyne NJ; Pyne S
Cell Signal; 2013 Apr; 25(4):1011-7. PubMed ID: 23314175
[TBL] [Abstract][Full Text] [Related]
10. FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells.
Tonelli F; Lim KG; Loveridge C; Long J; Pitson SM; Tigyi G; Bittman R; Pyne S; Pyne NJ
Cell Signal; 2010 Oct; 22(10):1536-42. PubMed ID: 20570726
[TBL] [Abstract][Full Text] [Related]
11. The roles of sphingosine kinase 1 and 2 in regulating the metabolome and survival of prostate cancer cells.
Tonelli F; Alossaimi M; Natarajan V; Gorshkova I; Berdyshev E; Bittman R; Watson DG; Pyne S; Pyne NJ
Biomolecules; 2013 Jun; 3(2):316-33. PubMed ID: 24970170
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2.
French KJ; Zhuang Y; Maines LW; Gao P; Wang W; Beljanski V; Upson JJ; Green CL; Keller SN; Smith CD
J Pharmacol Exp Ther; 2010 Apr; 333(1):129-39. PubMed ID: 20061445
[TBL] [Abstract][Full Text] [Related]
13. A novel sphingosine kinase inhibitor induces autophagy in tumor cells.
Beljanski V; Knaak C; Smith CD
J Pharmacol Exp Ther; 2010 May; 333(2):454-64. PubMed ID: 20179157
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression.
Schrecengost RS; Keller SN; Schiewer MJ; Knudsen KE; Smith CD
Mol Cancer Res; 2015 Dec; 13(12):1591-601. PubMed ID: 26271487
[TBL] [Abstract][Full Text] [Related]
15. A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes.
Shin SH; Kim HY; Yoon HS; Park WJ; Adams DR; Pyne NJ; Pyne S; Park JW
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171607
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts.
Beljanski V; Lewis CS; Smith CD
Cancer Biol Ther; 2011 Mar; 11(5):524-34. PubMed ID: 21258214
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma.
Venkata JK; An N; Stuart R; Costa LJ; Cai H; Coker W; Song JH; Gibbs K; Matson T; Garrett-Mayer E; Wan Z; Ogretmen B; Smith C; Kang Y
Blood; 2014 Sep; 124(12):1915-25. PubMed ID: 25122609
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II.
Cingolani F; Casasampere M; Sanllehí P; Casas J; Bujons J; Fabrias G
J Lipid Res; 2014 Aug; 55(8):1711-20. PubMed ID: 24875537
[TBL] [Abstract][Full Text] [Related]
19. ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer.
Yang J; Yang C; Zhang S; Mei Z; Shi M; Sun S; Shi L; Wang Z; Wang Y; Li Z; Xie C
Cancer Biol Ther; 2015; 16(8):1194-204. PubMed ID: 26054751
[TBL] [Abstract][Full Text] [Related]
20. Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.
Pyne NJ; McNaughton M; Boomkamp S; MacRitchie N; Evangelisti C; Martelli AM; Jiang HR; Ubhi S; Pyne S
Adv Biol Regul; 2016 Jan; 60():151-159. PubMed ID: 26429117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]